Metformin C4 Health

Metformin, the active ingredient in Metformin C4 Health, is a Biguanide presented as an oral tablet for oral use. It is used to improve blood glucose control in adults with type 2 diabetes mellitus and is also employed off‑label for polycystic ovary syndrome.

GNH USA supplies Metformin C4 Health as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and regulatory requirements to ensure product integrity across global markets throughout.

Metformin is used to manage hyperglycaemia in metabolic disorders.

- Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. - Polycystic ovary syndrome (off‑label): improves insulin resistance and may help regulate menstrual cycles. - Prediabetes (off‑label): delays progression to overt diabetes by improving glycaemic control.

Metformin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or diarrhoea. - Metallic taste in the mouth. - Decreased appetite. - Mild weight loss.

Serious or Rare Side Effects: - Lactic acidosis: a rare but potentially fatal metabolic complication. - Severe hypersensitivity reactions, including skin rash or angioedema.

Metformin should be used with caution and under medical supervision.

- Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic impairment: evaluate liver function as reduced clearance may increase risk of lactic acidosis. - Cardiovascular disease: monitor for signs of heart failure. - Concomitant contrast imaging: discontinue before and after iodinated contrast procedures. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Metformin may interact with several medicines, requiring monitoring.

Major Interactions (Avoid): - Iodinated contrast agents: can precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: may raise metformin plasma concentrations.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics: can affect renal function and alter metformin clearance. - Alcohol: excessive intake may potentiate lactic acidosis.